Glucose Health EBITDA Margin 2014-2019 | GLUC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Glucose Health ebitda margin from 2014 to 2019. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Glucose Health EBITDA Margin 2014-2019 | GLUC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Glucose Health ebitda margin from 2014 to 2019. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$206.3B
Stryker (SYK)	$148B
Boston Scientific (BSX)	$133.7B
EssilorLuxottica (ESLOY)	$111.2B
Medtronic (MDT)	$110.6B
Haleon (HLN)	$44B
Lonza Group Ag (LZAGY)	$42.2B
GE HealthCare Technologies (GEHC)	$37.9B
ResMed (RMD)	$36.6B
Terumo (TRUMY)	$30.3B
Koninklijke Philips (PHG)	$25.5B
Zimmer Biomet Holdings (ZBH)	$22.3B
Insulet (PODD)	$18.7B
Baxter (BAX)	$17B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$9.9B
Bio-Rad Laboratories (BIO)	$9.5B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.3B
TG Therapeutics (TGTX)	$5.4B
Haemonetics (HAE)	$4.4B
Prestige Consumer Healthcare (PBH)	$4.2B
Perrigo (PRGO)	$3.9B
ICU Medical (ICUI)	$3.9B
Envista Holdings (NVST)	$3.8B
Agios Pharmaceuticals (AGIO)	$3.3B
Neogen (NEOG)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B